Janus Henderson Group PLC Ptc Therapeutics, Inc. Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,981,559 shares of PTCT stock, worth $133 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,981,559
Previous 3,669,816
18.75%
Holding current value
$133 Million
Previous $107 Million
14.59%
% of portfolio
0.05%
Previous 0.06%
Shares
22 transactions
Others Institutions Holding PTCT
# of Institutions
226Shares Held
78.7MCall Options Held
135KPut Options Held
220K-
Vanguard Group Inc Valley Forge, PA8.97MShares$400 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.21MShares$366 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$347 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$330 Million3.78% of portfolio
-
Armistice Capital, LLC New York, NY6.96MShares$311 Million2.77% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.19B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...